AAAAI & ACAAI GUIDELINES Bundle (free trial)

Rhinitis

AAAAI & ACAAI GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/57870

Contents of this Issue

Navigation

Page 9 of 13

Table 4. Oral and Intranasal Antihistamines1 Generic Age limit Dose Second generation Acrivastine (Semprex-D® ≥ 12 y 8 mg PO qid ) Azelastine HCL (Astepro® Nasal) (Astelin Nasal® Cetirizine (Zyrtec® ) ≥ 12 y 5 y 0.1% (137 mcg/spray) ≥ 12 y 0.1% (137 mcg/spray) 0.15% (205.5 mcg/spray) 6 mo 5-10 mg PO daily ) OTC Desloratadine (Clarinex® Fexofenadine (Allegra® ) Levocetirizine (Xyzal® ) 6-11 y ≥ 12 y Loratadine (Claritin® 2 y ) Olopatadine HCL (Patanase® Brompheniramine (Lodrane XR® Clemastine (Tavist® Nasal) ) OTC Chlorpheniramine (Chlor-Trimeton® ) OTC Cyproheptadine (Periactin® ) Diphenhydramine (Benadryl® Hydroxyzine† (Atarax® ) Promethazine (Phenergan® Triprolidine (Zymine® ) 2 y ) OTC * Table revised aſter publication. In October 2008, many manufacturers added a warning in the < 4 year age group for all OTC cough and cold medications. Final FDA decision on age indications is pending. † Not FDA approved for AR. Note: abbreviations are defined on the back cover. 2.5 mg PO q4-6h 2 y ) OTC All ages 2 y 25 mg PO qid 25 mg PO qid 25-50 mg PO qid 2 y 4 mg PO qid ) OTC 6 y 1.34 mg PO bid to tid 2 y 4 mg PO tid 6-11 y ≥ 12 y 1 spray/nostril bid 2 spray/nostril bid 12 mg PO bid 6 mo 6 mo 5 mg PO daily ) OTC 2 y 180 mg PO daily or 60 mg PO bid 1.25 mg (2.5 mL) PO nightly 2.5 mg PO nightly 5 mg PO nightly 10 mg PO daily SAR: 1-2 sprays/nostril bid PAR: 2 sprays/nostril bid (SAR only): 1 spray/nostril bid SAR: 1-2 sprays/nostril bid SAR: 2 sprays/nostril daily PAR: 2 sprays/nostril bid 5, 10 mg 5 mg/mL 5 mg 2.5 mg/5 mL 30, 60, 180 mg 30 mg/5 mL 5 mg 10 mg 5 mg/5 mL 665 mcg/spray First generation* (FDA currently approved age indications listed) 2 y 2, 4, 8, 12, 16 mg 2, 4, 8 mg/5 mL 1.34, 2.68 mg .67 mg/5 mL 4 mg 2 mg/5 mL 25, 50 12.5 mg/mL 10, 25, 50, 100 mg 10, 25 mg/5 mL 12.5, 25, 50 mg 6.25 mg/mL 1.25, 2.5 mg/5 mL 6, 12 mg; 1, 2, 4, 8, 10, 12 mg/5 mL 11.5 (5.4) 1-3% (0%) 14 (10) 2.1 (1.8) 1.3 (0.9) 6 (2) 8 (6) 0.9 (0.3) 24 (5) 45 14 (1.5) 8-50 50 80 60-73 10-25 8 mg 8, 12 (6) Dosage forms % Sedation/ somnolence or CNS impairment (control) (Br and) FOR INTERNAL USE ONLY

Articles in this issue

Archives of this issue

view archives of AAAAI & ACAAI GUIDELINES Bundle (free trial) - Rhinitis